Literature DB >> 11127531

Polyneuropathy attributes: a comparison between patients with anti-MAG and anti-sulfatide antibodies.

S Erb1, F Ferracin, P Fuhr, K M Rösler, C W Hess, T Kuntzer, J Bogousslavsky, R Sztajzel, A J Steck.   

Abstract

Thirty-two patients with a peripheral neuropathy and paraproteinemia were tested for IgM antibodies against myelin-associated protein (MAG) and sulfatide by means of enzyme-linked immunosorbent assay. Nine patients (28 %) had increased anti-sulfatide IgM antibodies and showed a chronic, slowly progressive, distally pronounced, and symmetric polyneuropathy with sensory to sensory-motor impairment, ataxia, hyporeflexia, and axonal involvement in electrophysiological studies. Ten patients (31 %) with increased anti-MAG antibodies had a similar, homogeneous polyneuropathy syndrome but presented with demyelinating features. A weak cross-reactivity between anti-MAG and anti-sulfatide antibodies was present in only three patients. In conclusion, although the two neuropathy groups clearly differed in their electrophysiological features, their clinical presentation was rather similar.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127531     DOI: 10.1007/s004150070090

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  6 in total

1.  Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.

Authors:  Mohamed M El-Difrawy; Nadia E Zaki; Hazem M Marouf; Mona W Ayad; Ahmed M Farag
Journal:  Int J Hematol       Date:  2011-12-17       Impact factor: 2.490

2.  Peripheral neuropathies in Waldenström's macroglobulinaemia.

Authors:  T Levine; A Pestronk; J Florence; M T Al-Lozi; G Lopate; T Miller; I Ramneantu; W Waheed; M Stambuk; M J Stone; R Choksi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

3.  Tissue binding patterns and in vitro effects of Campylobacter jejuni DNA-binding protein from starved cells.

Authors:  Hua Piao; Motozumi Minohara; Nobutoshi Kawamura; Wei Li; Takuya Matsushita; Ryo Yamasaki; Yoshimitsu Mizunoe; Jun-Ichi Kira
Journal:  Neurochem Res       Date:  2010-09-19       Impact factor: 3.996

4.  Treatment of IgM antibody associated polyneuropathies using rituximab.

Authors:  A Pestronk; J Florence; T Miller; R Choksi; M T Al-Lozi; T D Levine
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

5.  CANOMAD and other chronic ataxic neuropathies with disialosyl antibodies (CANDA).

Authors:  Rocio Garcia-Santibanez; Craig M Zaidman; R Brian Sommerville; Glenn Lopate; Conrad C Weihl; Alan Pestronk; Robert C Bucelli
Journal:  J Neurol       Date:  2018-04-09       Impact factor: 4.849

6.  Anti-MAG IgM: differences in antibody tests and correlation with clinical findings.

Authors:  Sabrina Matà; Stefano Ambrosini; Domenica Saccomanno; Tiziana Biagioli; Marinella Carpo; Aldo Amantini; Fabio Giannini; Alessandro Barilaro; Lucia Toscani; Monica Del Mastio; Giacomo Pietro Comi; Sandro Sorbi
Journal:  Neurol Sci       Date:  2019-10-25       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.